Fny Investment Advisers, LLC Sarepta Therapeutics, Inc. Put Options Transaction History
Fny Investment Advisers, LLC
- $194 Million
- Q4 2024
Put Options
3 transactions
Others Institutions Holding SRPT
# of Institutions
528Shares Held
85MCall Options Held
1.74MPut Options Held
1.37M-
Black Rock Inc. New York, NY10.3MShares$1.16 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.09MShares$1.02 Billion0.02% of portfolio
-
Capital International Investors Los Angeles, CA6.26MShares$706 Million0.16% of portfolio
-
Janus Henderson Group PLC London, X04.36MShares$491 Million0.29% of portfolio
-
State Street Corp Boston, MA4.27MShares$481 Million0.02% of portfolio
About Sarepta Therapeutics, Inc.
- Ticker SRPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,567,904
- Market Cap $9.87B
- Description
- Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...